甲基氧化偶氮甲醇乙酸酯精神分裂症模型的转化相关性:行为与神经生物学发现的系统综述
该研究遵循PRISMA 2020与CAMARADES指南,系统检索PubMed、Embase和Web of Science,纳入53项使用妊娠期MAM模型的大鼠或小鼠原始研究,从行为、生理、组织学、遗传和药理学五个预设域综合发现。证据汇聚于腹侧海马-伏隔核-腹侧被盖区环路过度活跃导致纹状体多巴胺过量这一病理生理轴,并与人类死后、神经影像和PET证据双向对应。模型可用于新一代非D2疗法的临床前筛选。
要点
- MAM模型重现腹侧海马-伏隔核-腹侧被盖区环路过度活跃及纹状体多巴胺过量。
- 该病理轴与人类死后、神经影像和PET证据双向对应。
- 卵巢激素调节下游环路读出而非上游细胞损伤,解释雌性行为表型减弱。
核心结论
- MAM模型重现精神分裂症汇聚性环路水平病理生理,适合作为新一代非D2疗法的临床前筛选平台。
- 方法学统一、雌雄混合队列和纵向设计对实现转化潜力至关重要。
研究设计与样本
- 遵循PRISMA 2020和CAMARADES指南的系统综述,检索PubMed、Embase和Web of Science。
- 纳入53项使用妊娠期MAM模型的大鼠或小鼠原始研究。
- 按行为、生理、组织学、遗传和药理学五个预设域综合发现。
主要发现
- 证据汇聚于单一病理生理轴:妊娠期腹侧海马(vHP)和内侧前额叶皮层破坏导致小清蛋白中间神经元丢失、局部兴奋/抑制失衡及vHP-伏隔核-腹侧被盖区环路过度活跃,最终引起纹状体多巴胺过量。
- 该轴与人类死后、神经影像和正电子发射断层扫描(PET)证据双向对应。
- 性别分层发现提示卵巢激素调节下游环路读出而非上游细胞损伤,解释雌性动物行为表型减弱但细胞病理保留。
临床怎么用
- MAM模型可作为临床前筛选平台,用于评估毒蕈碱、TAAR1和α5-GABAAR等非D2靶点疗法。
- 解读雌性动物行为结果时需考虑卵巢激素对下游环路读出的调节作用。
局限性
- 既往系统综述仅限于行为表型,本文虽扩展至五个域但仍基于临床前模型。
- 文献碎片化,需方法学统一、雌雄混合队列和纵向设计以充分实现转化潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia is a neurodevelopmental psychiatric disorder whose circuit-level mechanisms remain incompletely understood. Among preclinical platforms, the methylazoxymethanol acetate (MAM) gestational model uniquely recapitulates the developmental, multidomain pathophysiology of schizophrenia, but the literature is fragmented, and prior systematic reviews have been limited to behavioral phenotypes. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 and CAMARADES (Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies) guidelines, we systematically searched PubMed, Embase, and Web of Science for original studies using the gestational MAM model in rats or mice. Findings were synthesized across 5 prespecified domains: behavioral, physiological, histological, genetic, and pharmacological. Of the 53 included studies, evidence converged on a single pathophysiological axis: gestational disruption of the ventral hippocampus (vHP) and medial prefrontal cortex produces parvalbumin interneuron loss, local excitatory/inhibitory imbalance, and vHP-nucleus accumbens-ventral tegmental area circuit hyperactivity, culminating in striatal dopamine excess. This axis maps bidirectionally to human postmortem, neuroimaging, and positron emission tomography evidence. Sex-stratified findings suggest that ovarian hormones modulate downstream circuit readout rather than the upstream cellular insult, accounting for attenuated behavioral phenotypes in female animals despite preserved cellular pathology. The MAM model recapitulates a convergent circuit-level pathophysiology of schizophrenia and is well positioned as a preclinical screening platform for next-generation non-D2 therapeutics, including the muscarinic, TAAR1 (trace amine-associated receptor 1), and α5-GABAAR (α5 subunit-containing gamma-aminobutyric acid type A receptor) approaches now entering clinical practice. Methodological harmonization, mixed-sex cohorts, and longitudinal designs will be critical to fully realize this translational potential.
引用
- Lee T, Eom K, Kim JJ, et al. Translational Relevance of the Methylazoxymethanol Acetate Model in Schizophrenia: A Systematic Review of Behavioral and Neurobiological Findings. Biol Psychiatry. 2026. PMID: 42419666. doi:10.1016/j.biopsych.2026.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。